TABLE 2. Patient assessments/scores pre- and post-treatment (low level laser therapy) during hospitalization.
| Parameters | Pre-treatment | Post-treatment | Normal range or evaluation criteria |
|---|---|---|---|
| SMART-COP, evaluates pneumonia severity | 5 | 1 | 0 points: Very low risk of needing IRVS 1 point: Low risk (1 in 20) of needing IRVS 2 points: Moderate risk (1 in 10) of needing IRVS 3 points: High risk (1 in 6) of needing IRVS ≥4 points: High risk (1 in 3) of needing IRVS; consider admission to intensive care unit |
| Brescia-COVID respiratory severity scale | 4 | 0 | 0 – monitor 1 – add O2 and monitor 2 – chest X-ray, arterial blood gas, O2 therapy, monitor >2 – High-flow nasal cannula and reassess. If still >2, intubate. |
| Radiographic assessment of lung edema | 8 | 2 | Lungs score dependent on extent of involvement based on consolidation or ground glass opacities for each lung, total score is the sum of the score of the lungs: 0 = no involvement. 1 = <25%; 2 = 25%–50%; 3 = 50%–75%; 4 = >75% |
| Interleukin-6 | 45.89 | 11.7 | <5 pg/mL |
| C-reactive protein | 3.06 | 1.43 | 0–0.8 mg/dL |
| O2 requirement | 3–6 L/min | 0–1 L/min | 0 L/min |
| Oxygen saturation | 88%–93% | 97% | ≥94% |
| Ferritin | 359 | 175 | 11–307 ng/mL, in females |
| White blood cells | 4.4 | 4.9 | 4.5–11 K/uL |
| Hemoglobin | 10.6 | 9.0 | 12.0–15.5 g/dL |
| Hematocrit | 36 | 30 | 37%–48% for women |
| Albumin | 3.7 | 3.3 | 3.4–5.4 g/dL |
SMART-COP, systolic blood pressure, multilobar infiltrates, albumin, respiratory rate, tachycardia, confusion, oxygen, and pH; IRVS, intensive respiratory or vasopressor support.